{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:06:14Z","timestamp":1786997174091,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.suc.2005.05.006","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T07:12:52Z","timestamp":1125558772000},"page":"895-906","source":"Crossref","is-referenced-by-count":9,"title":["Medical Management of Acid-Peptic Disorders of the Stomach"],"prefix":"10.1016","volume":"85","author":[{"given":"Sheila","family":"Eswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suc.2005.05.006_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0016-5085(19)33606-6","article-title":"Gastric mucosal barrier","volume":"61","author":"Ivey","year":"1971","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2005.05.006_bib2","series-title":"Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management","author":"Sleisenger","year":"2002"},{"issue":"5A","key":"10.1016\/j.suc.2005.05.006_bib3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(96)80223-3","article-title":"Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence","volume":"100","author":"Mobley","year":"1996","journal-title":"Am J Med"},{"issue":"24","key":"10.1016\/j.suc.2005.05.006_bib4","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.suc.2005.05.006_bib5","series-title":"Textbook of gastroenterology","author":"Yamada","year":"1999"},{"issue":"1","key":"10.1016\/j.suc.2005.05.006_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/j.1875-9114.1998.tb03830.x","article-title":"Reviews of therapeutics. Update: clinically significant cytochrome P-450 drug interactions","volume":"18","author":"Michalets","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2005.05.006_bib7","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1016\/j.suc.2005.05.006_bib8","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.suc.2005.05.006_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostal for ulcers associated with non-steroidal anti-inflammatory drugs: omeprazole vs. misoprostol for NSAID-induced ulcer management. (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.suc.2005.05.006_bib10","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drug","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2005.05.006_bib11","unstructured":"Cardinal Health. Avialable at: http:\/\/www.cardinal.com\/. Accessed April 1, 2005."},{"issue":"12","key":"10.1016\/j.suc.2005.05.006_bib12","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection","volume":"93","author":"Howden","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"10.1016\/j.suc.2005.05.006_bib13","first-page":"1","article-title":"Consensus guidelines offer more effective management of Helicobacter pylori-related disease","volume":"11","author":"Rollins","year":"2000","journal-title":"Rep Med Guidel Outcomes Res"},{"issue":"5","key":"10.1016\/j.suc.2005.05.006_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/0016-5085(90)91197-E","article-title":"Treatment of NSAID-induced gastroduodenal ulcers","volume":"99","author":"Schubert","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2005.05.006_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJM198403223101205","article-title":"Omeprazole in Zollinger-Ellison syndrome","volume":"310","author":"Lamers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.suc.2005.05.006_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0016-5085(89)91485-6","article-title":"Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study","volume":"97","author":"Maton","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2005.05.006_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1572-0241.2003.07262.x","article-title":"Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion","volume":"98","author":"Metz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.suc.2005.05.006_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1542-3565(04)00606-8","article-title":"Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study","volume":"3","author":"Hirschowitz","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2005.05.006_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0016-5085(90)91223-S","article-title":"Intravenous omprazole in patients with Zollinger-Ellison syndrome undergoing surgery","volume":"99","author":"Vinayek","year":"1990","journal-title":"Gastroenterology"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610905000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610905000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T05:58:54Z","timestamp":1683179934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610905000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0039610905000812"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2005.05.006","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}